# Connectome-GNN-Suite Roadmap

## Vision
To become the leading open-source platform for graph neural network analysis of brain connectivity data, enabling breakthrough discoveries in neuroscience and clinical applications.

## Release Timeline

### v0.1.0 - Foundation Release (Current) ✅
**Target: Q1 2025** | **Status: Released**

**Core Features:**
- [x] Basic connectome data loading and preprocessing
- [x] Hierarchical Brain GNN implementation
- [x] HCP dataset integration
- [x] Basic visualization tools
- [x] Unit test framework
- [x] Documentation structure

**Key Deliverables:**
- [x] PyTorch Geometric integration
- [x] Memory-efficient graph handling
- [x] Example notebooks and tutorials
- [x] CI/CD pipeline foundation

---

### v0.2.0 - Multi-Modal Release 
**Target: Q2 2025** | **Status: In Development**

**Major Features:**
- [ ] Multi-modal data fusion (structural + functional)
- [ ] Temporal connectome GNN for dynamic connectivity
- [ ] Enhanced preprocessing pipeline with ComBat harmonization
- [ ] Interactive 3D brain visualization with Plotly
- [ ] Comprehensive benchmarking suite

**Performance Goals:**
- Handle graphs up to 100k nodes efficiently
- Support batch processing of multiple subjects
- Achieve competitive performance on HCP cognitive prediction tasks

**Technical Improvements:**
- [ ] Gradient checkpointing for memory efficiency
- [ ] Mixed precision training support
- [ ] Distributed training capabilities
- [ ] Advanced graph sampling strategies

---

### v0.3.0 - Clinical Translation Release
**Target: Q3 2025** | **Status: Planned**

**Clinical Features:**
- [ ] Disease classification models (Autism, Alzheimer's, Schizophrenia)
- [ ] Clinical validation on ADNI and ABIDE datasets
- [ ] Federated learning support for multi-site studies
- [ ] DICOM integration for clinical workflows
- [ ] Regulatory compliance documentation (FDA guidance)

**Interpretability Tools:**
- [ ] SubgraphCLIP for brain region explanation
- [ ] Attention visualization and analysis
- [ ] Gradient-based feature attribution
- [ ] Clinical report generation

**Security & Privacy:**
- [ ] Differential privacy mechanisms
- [ ] Secure multi-party computation
- [ ] HIPAA compliance features
- [ ] Audit logging and compliance monitoring

---

### v0.4.0 - Foundation Model Release
**Target: Q4 2025** | **Status: Research Phase**

**Foundation Model Features:**
- [ ] Self-supervised pre-training on large connectome datasets
- [ ] Transfer learning across different brain atlases
- [ ] Multi-species connectome support (human, macaque, mouse)
- [ ] Zero-shot prediction capabilities
- [ ] Model distillation for edge deployment

**Advanced Architectures:**
- [ ] Graph Transformers for connectome analysis
- [ ] Causal discovery in brain networks
- [ ] Population-level graph neural networks
- [ ] Neuromorphic computing integration

**Research Collaborations:**
- [ ] Integration with major neuroimaging consortiums
- [ ] Academic partnership program
- [ ] Open dataset contributions
- [ ] Reproducible research framework

---

### v1.0.0 - Production Release
**Target: Q1 2026** | **Status: Vision**

**Production Features:**
- [ ] Clinical deployment package
- [ ] Real-time inference capabilities
- [ ] Cloud-native deployment (AWS, GCP, Azure)
- [ ] Professional support and training
- [ ] Enterprise security features

**Ecosystem Integration:**
- [ ] Integration with major neuroimaging platforms (FSL, FreeSurfer, SPM)
- [ ] Plugin architecture for third-party extensions
- [ ] RESTful API for web applications
- [ ] Mobile app for clinicians

**Community & Governance:**
- [ ] Scientific advisory board
- [ ] Open governance model
- [ ] Community grants program
- [ ] Annual user conference

---

## Research Priorities

### Short-term (2025)
1. **Scalability**: Handle connectomes with 1M+ nodes
2. **Multi-modal Fusion**: Effective integration of structural/functional data
3. **Clinical Validation**: Demonstrate clinical utility in pilot studies
4. **Interpretability**: Tools for understanding model decisions

### Medium-term (2025-2026)
1. **Foundation Models**: Pre-trained models for brain connectivity
2. **Causal Discovery**: Identify causal relationships in brain networks
3. **Personalized Medicine**: Individual-specific brain models
4. **Real-time Processing**: Online analysis of streaming brain data

### Long-term (2026+)
1. **Brain-Computer Interfaces**: Integration with BCI systems
2. **Drug Discovery**: Connectome-guided therapeutic development
3. **Developmental Models**: Lifespan brain connectivity modeling
4. **Precision Psychiatry**: Personalized mental health treatments

---

## Technical Milestones

### Performance Targets
- **v0.2.0**: Support 100k node graphs, 8GB GPU memory
- **v0.3.0**: Clinical-grade accuracy (>90% on diagnostic tasks)
- **v0.4.0**: Foundation model with <1% fine-tuning for new tasks
- **v1.0.0**: Real-time inference (<100ms for single subject)

### Scalability Goals
- **Current**: Single GPU, small cohorts (<1000 subjects)
- **v0.2.0**: Multi-GPU, medium cohorts (1000-10000 subjects)
- **v0.3.0**: Distributed training, large cohorts (>10000 subjects)
- **v1.0.0**: Cloud-scale, population studies (>100000 subjects)

---

## Community Engagement

### Academic Partnerships
- **Current**: Individual researcher adoption
- **v0.2.0**: University lab integrations
- **v0.3.0**: Multi-site consortium studies
- **v1.0.0**: Global research network

### Industry Collaboration
- **Medical Device Companies**: Integration with neuroimaging hardware
- **Pharmaceutical Companies**: Drug development applications  
- **Healthcare Providers**: Clinical deployment partnerships
- **Cloud Providers**: Optimized deployment solutions

### Open Source Ecosystem
- **Contributions**: Welcoming pull requests and feature proposals
- **Documentation**: Comprehensive tutorials and API documentation
- **Community**: Discord server, monthly developer calls
- **Events**: Workshop presentations, conference tutorials

---

## Risk Assessment & Mitigation

### Technical Risks
- **Memory Limitations**: Mitigated by hierarchical sampling and gradient checkpointing
- **Model Complexity**: Addressed through modular architecture and comprehensive testing
- **Data Privacy**: Handled via federated learning and differential privacy

### Market Risks
- **Competition**: Differentiate through clinical focus and interpretability
- **Regulatory**: Engage early with FDA/EMA for guidance
- **Adoption**: Focus on ease of use and comprehensive documentation

### Resource Risks
- **Funding**: Diversify through academic grants, industry partnerships
- **Talent**: Open source community building and internship programs
- **Infrastructure**: Cloud partnerships for computational resources

---

## Success Metrics

### Adoption Metrics
- **GitHub Stars**: Target 1000+ by v0.3.0
- **PyPI Downloads**: Target 10k+ monthly by v0.4.0
- **Academic Citations**: Target 100+ by v1.0.0
- **Clinical Deployments**: Target 10+ pilot sites by v1.0.0

### Technical Metrics
- **Model Performance**: State-of-the-art on standard benchmarks
- **Scalability**: Support for largest available datasets
- **Reliability**: >99.9% uptime for production deployments
- **Security**: Zero critical vulnerabilities

### Impact Metrics
- **Research Acceleration**: Enable 50+ published studies
- **Clinical Translation**: 5+ FDA-approved applications
- **Educational Impact**: 1000+ trained users globally
- **Economic Value**: $10M+ in research cost savings

---

*This roadmap is updated quarterly based on community feedback, technical progress, and research priorities. Last updated: Q1 2025*